
Ambelvist adds lower-dose GBCA option for MRI
FDA approval covers gadoquatrane for detecting and visualizing lesions with abnormal vascularity in CNS and non-CNS body regions across adult and pediatric patients.
Section
Every story we've published, newest first. 318 articles.

FDA approval covers gadoquatrane for detecting and visualizing lesions with abnormal vascularity in CNS and non-CNS body regions across adult and pediatric patients.

The 18-month University of Sydney research program will use Micro-X NEX tubes to assess a miniaturized stationary CT concept for lung imaging applications.

The agreement gives Ratio Therapeutics another cGMP Actinium-225 source for ongoing clinical trial activity and future targeted radiotherapeutic programs.

The proposed class action alleges Nano-X overstated demand and operational efficiency before reporting a $33.4M quarterly loss and a Korean facility impairment charge.

A JAMA Network Open cohort study found that 43 of 903 FDA-authorized AI-enabled medical devices were recalled, with missing clinical-study information linked to higher recall hazard.

Boston University and Radboudumc researchers will co-lead TRAFFIC, a 5-year effort combining brain imaging, molecular biomarkers, experimental models, and clinical data.

The Senate passed S. 1157 on June 8, but House and Senate lawmakers still need identical language before the legislation can go to the president.

The multiyear agreement restores in-network access to Golden State Imaging Associates’ diagnostic and interventional radiology services, effective June 1, 2026.

Mass General Brigham radiologists will evaluate 3 MediAI tools for bone age, full lower-limb measurement, and scoliosis severity against clinical interpretations.

The clearance covers AI/ML software for processing and enhancing CT images regardless of scanner manufacturer or model, according to FDA records.